A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors

NCT06413615 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: FDA022-BB05

Sponsor

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.